Panax Ginseng in the treatment of Alzheimer's disease and vascular dementia
- PMID: 37397417
- PMCID: PMC10310864
- DOI: 10.1016/j.jgr.2023.03.001
Panax Ginseng in the treatment of Alzheimer's disease and vascular dementia
Abstract
Dementia has become one of the most important diseases threatening human health. Alzheimer's disease (AD) and vascular dementia (VaD) have the highest incidence rates among the types of dementia, but until now, therapeutic methods have been limited. Panax ginseng has been used in China for thousands of years to treat dementia, and modern medical studies have found that it contains multiple active components, such as ginsenosides, polysaccharides, amino acids, volatile oils and polyacetylenes, many of which have therapeutic effects in treating AD and VaD. Studies have found that ginsenosides have multitarget therapeutic effects in treating dementia, such as regulation of synaptic plasticity and the cholinergic system, inhibition of Aβ aggravation and tau hyperphosphorylation, anti-neuroinflammation, anti-oxidation effects and anti-apoptosis effects. Other active components of Panax ginseng, such as gintonin, oligosaccharides, polysaccharides and ginseng proteins, also have therapeutic effects on AD and VaD. The effectiveness of ginseng-containing Chinese medicine compounds has also been confirmed by clinical and basic investigations in treating AD and VaD. In this review, we summarized the potential therapeutic effects and related mechanisms of Panax ginseng in treating AD and VaD to provide some examples for further studies.
Keywords: Alzheimer's disease; Chinese medicine; Ginsenosides; Panax ginseng; Vascular dementia.
© 2023 The Korean Society of Ginseng. Publishing services by Elsevier B.V.
Conflict of interest statement
All authors have no conflicts of interest to declare.
Figures
Similar articles
-
Panax ginseng as an adjuvant treatment for Alzheimer's disease.J Ginseng Res. 2018 Oct;42(4):401-411. doi: 10.1016/j.jgr.2017.12.008. Epub 2018 Jan 12. J Ginseng Res. 2018. PMID: 30337800 Free PMC article. Review.
-
American Ginseng for the Treatment of Alzheimer's Disease: A Review.Molecules. 2023 Jul 28;28(15):5716. doi: 10.3390/molecules28155716. Molecules. 2023. PMID: 37570686 Free PMC article. Review.
-
Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences.Front Pharmacol. 2021 Jun 2;12:688490. doi: 10.3389/fphar.2021.688490. eCollection 2021. Front Pharmacol. 2021. PMID: 34149431 Free PMC article. Review.
-
Panax ginseng against myocardial ischemia/reperfusion injury: A review of preclinical evidence and potential mechanisms.J Ethnopharmacol. 2023 Jan 10;300:115715. doi: 10.1016/j.jep.2022.115715. Epub 2022 Sep 13. J Ethnopharmacol. 2023. PMID: 36108895 Review.
-
Active Compounds of Panax ginseng in the Improvement of Alzheimer's Disease and Application of Spatial Metabolomics.Pharmaceuticals (Basel). 2023 Dec 26;17(1):38. doi: 10.3390/ph17010038. Pharmaceuticals (Basel). 2023. PMID: 38256872 Free PMC article. Review.
Cited by
-
Ginsenoside Re Regulates Oxidative Stress through the PI3K/Akt/Nrf2 Signaling Pathway in Mice with Scopolamine-Induced Memory Impairments.Curr Issues Mol Biol. 2024 Oct 13;46(10):11359-11374. doi: 10.3390/cimb46100677. Curr Issues Mol Biol. 2024. PMID: 39451557 Free PMC article.
-
A review of SaiLuoTong (MLC-SLT) development in vascular cognitive impairment and dementia.Front Pharmacol. 2024 May 1;15:1343820. doi: 10.3389/fphar.2024.1343820. eCollection 2024. Front Pharmacol. 2024. PMID: 38751782 Free PMC article. Review.
-
Computational Assessment of the Phytochemicals of Panax ginseng C.A. Meyer Against Dopamine Receptor D1 for Early Huntington's Disease Prophylactics.Cell Biochem Biophys. 2024 Dec;82(4):3413-3423. doi: 10.1007/s12013-024-01426-2. Epub 2024 Jul 24. Cell Biochem Biophys. 2024. PMID: 39046621
-
Effect of ginseng and ginsenosides on attention deficit hyperactivity disorder: A systematic review.J Ginseng Res. 2024 Sep;48(5):437-448. doi: 10.1016/j.jgr.2024.05.006. Epub 2024 May 28. J Ginseng Res. 2024. PMID: 39263306 Free PMC article. Review.
-
Efficacy and Safety of Panax ginseng Sprout Extract in Subjective Memory Impairment: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Nutrients. 2024 Jun 19;16(12):1952. doi: 10.3390/nu16121952. Nutrients. 2024. PMID: 38931306 Free PMC article. Clinical Trial.
References
-
- Livingston G., Sommerlad A., Orgeta V., Costafreda S., Huntley J., Ames D., et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673–2734. - PubMed
-
- Cao Q., Tan C.C., Xu W., Hu H., Cao X.P., Dong Q., et al. The prevalence of dementia: a systematic review and meta-analysis. Journal of Alzheimer’s Disease. 2020;73(3):1157–1166. - PubMed
-
- Jia L., Du Y., Chu L., Zhang Z., Li F., Lyu D., Li Y., Li Y., Zhu M., Jiao H., et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. The Lancet Public Health. 2020;5(12):e661–e671. - PubMed
-
- Tisher A., Salardini A. A comprehensive update on treatment of dementia. Seminars in Neurology. 2019;39(2):167–178. - PubMed
Publication types
LinkOut - more resources
Full Text Sources